Dr Mary Kerr, CEO of KaNDy Therapeutics to present at the Biotech Showcase in San Francisco on 14 January 2020, at 11.00, Franciscan B (Ballroom Level)
Dr Mary Kerr, will be presenting the latest clinical developments from KaNDy’s NT-814 study, a potential breakthrough and non-hormonal alternative for symptoms of the menopause.